Table 3.
Univariable Cox regression analyses for the volumes of interest of TLG
Overall survival | Disease-free survival | |||||
---|---|---|---|---|---|---|
HR (95% CI)ª | p-value | C-index | HR (95% CI)ª | p-value | C-index | |
T TLG with SUV2.5 threshold | 1.001 (10,004–1.003) | 0.009 | 0.652 | 1.003 (1.001–1.004) | 0.001 | 0.693 |
N TLG with SUV2.5 threshold | 1.002 (1.001–1.003) | 0.005 | 0.586 | 1.001 (1.001–1.002) | 0.014 | 0.586 |
T + N with TLG SUV2.5 threshold | 1.001 (1.001–1.002) | 0.001 | 0.660 | 1.001 (1.001–1.002) | < 0.001 | 0.706 |
T TLG with background-level threshold | 1.001 (1.01–1.001) | 0.281 | 0.629 | 1.001 (1.01–1.001) | 0.245 | 0.671 |
N TLG with background-level threshold | 1.002 (1.001–1.003) | 0.006 | 0.545 | 1.001 (1.001–1.002) | 0.020 | 0.566 |
T + N TLG with background-level threshold | 1.001 (1.001–1.002) | 0.001 | 0.649 | 1.001 (1.001–1.002) | < 0.001 | 0.694 |
ªPer unit increment
HR hazard ratio, CI confidence interval, TLG total lesion glycolysis, C-index Harrell’s C-index, SUV standardized uptake value, T tumor, N lymph node